Boehringer Ingelheim has penned a $500 million deal with a British biotech for a preclinical program the German pharma hopes could offer a fresh oral treatment approach to a variety of autoimmune a | ...

Explore powerful insights and solutions about building strong entry-talent strategies from a few of Year Up United’s deep, ...

Red Raiders are looking to string together top signing classes as several impact recruits expected in Lubbock this spring ...

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.

Phase III study will be "sufficient and pivotal for registration in the U.S." Kiniksa Pharmaceuticals ( KNSA +1.56%) ...

The global AI race is now about talent, not markets. Closing a 4.2M skills gap by 2030 demands ecosystem-led, industry-academic talent development.

The CRN 2026 Partner Program Guide includes software vendor partner programs that are designated 5-Star programs.

Q4 2025 earnings call: record leasing, 98.1% occupancy, higher FFO and 2026 guidance, plus debt refinancing and risks.

Q4 2025 Earnings Call February 24, 2026 10:00 AM ESTCompany ParticipantsStephen Vather - Senior VP of Corporate ...

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

When star safety and team leader Xavion Alford was lost due to injury, there was a significant void left in the secondary.